nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—chronic obstructive pulmonary disease	0.703	1	CbGaD
Gadobenate Dimeglumine—ALB—Prednisone—chronic obstructive pulmonary disease	0.0354	1	CbGbCtD
Gadobenate Dimeglumine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000278	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000274	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000268	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000266	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000266	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000261	0.000997	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.000989	CcSEcCtD
Gadobenate Dimeglumine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.000983	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.000979	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000256	0.000979	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000255	0.000974	CcSEcCtD
Gadobenate Dimeglumine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.000973	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00097	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.000966	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.000961	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00025	0.000957	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.000956	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00025	0.000955	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.000955	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000247	0.000942	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000245	0.000935	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000245	0.000934	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.000934	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000244	0.000931	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.000931	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000242	0.000925	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.000924	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.000922	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000241	0.000922	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000241	0.000922	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.000919	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000239	0.000912	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000238	0.00091	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.000905	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000237	0.000905	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000236	0.000903	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.000903	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000236	0.000903	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.000901	CcSEcCtD
Gadobenate Dimeglumine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000235	0.000896	CcSEcCtD
Gadobenate Dimeglumine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.000896	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.000896	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000235	0.000896	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.000888	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000232	0.000886	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000232	0.000885	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.000882	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00088	CcSEcCtD
Gadobenate Dimeglumine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00023	0.000878	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000229	0.000875	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.000871	CcSEcCtD
Gadobenate Dimeglumine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000227	0.000868	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000227	0.000867	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.000865	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.000863	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000226	0.000863	CcSEcCtD
Gadobenate Dimeglumine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000226	0.000862	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00086	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000225	0.000859	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.000857	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000224	0.000857	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.000854	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000853	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.000846	CcSEcCtD
Gadobenate Dimeglumine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.000846	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00022	0.000839	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.000832	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000218	0.000832	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000217	0.000828	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.000828	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.000828	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000217	0.000828	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000216	0.000825	CcSEcCtD
Gadobenate Dimeglumine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000214	0.000819	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000214	0.000818	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000214	0.000818	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000213	0.000815	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.000815	CcSEcCtD
Gadobenate Dimeglumine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000213	0.000813	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000813	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000212	0.000811	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000212	0.000811	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00081	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.000809	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000798	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.000786	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000782	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000782	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000202	0.000772	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.000772	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000202	0.000771	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00077	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000198	0.000756	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.000752	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000197	0.000752	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.000741	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000194	0.000741	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00074	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000193	0.000736	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.000729	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00019	0.000726	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000188	0.000717	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.000717	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000714	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00071	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000184	0.000702	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.0007	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000695	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000181	0.000693	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.000693	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000178	0.000679	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.000677	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.000666	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000174	0.000666	CcSEcCtD
Gadobenate Dimeglumine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000173	0.000661	CcSEcCtD
Gadobenate Dimeglumine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.000661	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00066	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00066	CcSEcCtD
Gadobenate Dimeglumine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000172	0.000656	CcSEcCtD
Gadobenate Dimeglumine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.000656	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.000654	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000654	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000171	0.000653	CcSEcCtD
Gadobenate Dimeglumine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000169	0.000647	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000169	0.000646	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.000645	CcSEcCtD
Gadobenate Dimeglumine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000168	0.000643	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000635	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.000629	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.000627	CcSEcCtD
Gadobenate Dimeglumine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000624	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000624	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000623	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000163	0.000622	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.000622	CcSEcCtD
Gadobenate Dimeglumine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00062	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000611	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00061	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.0006	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000591	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000588	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000585	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00057	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000567	CcSEcCtD
Gadobenate Dimeglumine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000558	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000554	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000549	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000542	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000527	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000524	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00051	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000508	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000469	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000468	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000467	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000462	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000456	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000453	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000451	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000444	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00043	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00043	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000429	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000427	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000425	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000412	CcSEcCtD
Gadobenate Dimeglumine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000406	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000404	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000402	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000401	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000399	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.83e-05	0.000376	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.82e-05	0.000375	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	9.69e-05	0.00037	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	9.5e-05	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Rash—Prednisolone—chronic obstructive pulmonary disease	9.37e-05	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.36e-05	0.000357	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.000356	CcSEcCtD
Gadobenate Dimeglumine—Headache—Prednisolone—chronic obstructive pulmonary disease	9.31e-05	0.000355	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Prednisone—chronic obstructive pulmonary disease	9.23e-05	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.89e-05	0.00034	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.000337	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.82e-05	0.000337	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.57e-05	0.000328	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.95e-05	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.74e-05	0.000296	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.64e-05	0.000292	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.000282	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.14e-05	0.000273	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.86e-05	0.000262	CcSEcCtD
Gadobenate Dimeglumine—Rash—Prednisone—chronic obstructive pulmonary disease	6.81e-05	0.00026	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.8e-05	0.00026	CcSEcCtD
Gadobenate Dimeglumine—Headache—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.000258	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Prednisone—chronic obstructive pulmonary disease	6.41e-05	0.000245	CcSEcCtD
